TerrAscend (OTCMKTS:TSNDF) and Guided Therapeutics (OTCMKTS:GTHP) Head to Head Analysis

TerrAscend (OTCMKTS:TSNDF) and Guided Therapeutics (OTCMKTS:GTHP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability.

Insider and Institutional Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are owned by institutional investors. 31.6% of TerrAscend shares are owned by insiders. Comparatively, 66.8% of Guided Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares TerrAscend and Guided Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-45.86%	-24.69%	-4.46%
Guided Therapeutics	N/A	N/A	-274.24%

Risk and Volatility

TerrAscend has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500.

Earnings & Valuation

This table compares TerrAscend and Guided Therapeutics”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TerrAscend	$260.56 million	0.84	-$81.33 million	($0.10)	-7.10
Guided Therapeutics	$770,000.00	28.59	-$3.20 million	($0.04)	-5.70

Guided Therapeutics has lower revenue, but higher earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Guided Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for TerrAscend and Guided Therapeutics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	1	3.00
Guided Therapeutics	0	0	0	0	0.00

Summary

Guided Therapeutics beats TerrAscend on 8 of the 13 factors compared between the two stocks.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.